• TRADE NAMES: Alopexy; Apo-Gain; Hairgaine; Loniten (Par); Lonolox; Lonoten; Minoximen; Regaine; Rogaine (Pfizer)
  • INDICATIONS: Hypertension, androgenetic alopecia
  • CLASS: Vasodilator
  • HALF-LIFE: 4.2 hours

Topical [T]

Please login to view the rest of this drug profile.

    DRUG REVIEW ARTICLE

    Click on the DRUG REVIEW ARTICLE tab (above) to see a review of minoxidil in the Taylor & Francis journal Expert Opinion on Drug Safety.

    (Note that non-subscribers to the journal will only be able to see an abstract of the article.)

Page last updated 02/15/2025

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric